tiprankstipranks
Zura Bio Announces CEO Transition and Executive Compensation Details
Company Announcements

Zura Bio Announces CEO Transition and Executive Compensation Details

Don't Miss Our Christmas Offers:

Zura Bio (ZURA) has provided an update.

Zura Bio Limited has navigated a CEO transition, with Someit Sidhu stepping down and Robert Lisicki taking over on April 8, 2024. Sidhu’s departure comes with a financial package including salary, notice, termination compensation, and severance totaling over $555,000. Additionally, Sidhu’s stock options will accelerate, making 1,000,000 shares immediately exercisable, with more vesting over the next three years. His contribution to a recent capital raise also ensures 700,000 shares remain exercisable until expiration.

See more data about ZURA stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskZura Bio to Present at Healthcare Conference
TipRanks Auto-Generated NewsdeskZura Bio Announces Phase 2 Tibulizumab Study
TheFlyZura Bio submits protocol to FDA for Phase 2 study of Tibulizumab
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App